Aaron Rodriguez+FollowPenn’s Blood Cancer Breakthroughs Are WildBlood cancer research just got a major glow-up! Penn Medicine’s team is dropping some jaw-dropping updates at the ASH meeting—think new treatments for leukemia, immune disorders, and even long-term CAR T cell therapy results. Over 75% of patients are still alive after five years, and some new antibody combos are showing insane promise. Plus, Penn’s top docs are getting big honors. Feels like we’re watching history in the making! #Health #BodyHealth #BloodCancer70Share
